HC Wainwright & Co. Initiates Coverage On HilleVax with Buy Rating, Announces Price Target of $28
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Matthew Caufield has initiated coverage on HilleVax (NASDAQ:HLVX) with a Buy rating and set a price target of $28.
December 13, 2023 | 11:25 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HilleVax receives a Buy rating from HC Wainwright & Co. with a price target of $28, indicating a positive outlook from the analyst.
The initiation of coverage by an analyst with a Buy rating typically suggests a positive outlook on the stock's future performance. The price target of $28 implies a significant upside potential from the current trading price, which may attract investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100